Quinquenoside F1



Compound IDCDAMM02850
Common nameQuinquenoside F1
IUPAC name2-[4,5-dihydroxy-6-(hydroxymethyl)-2-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-(2,5,6-trihydroxy-6-methylheptan-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formulaC42H74O15

Experimental data

Retention time20.81
Adduct[M+Na]+
Actual mz841.485
Theoretical mz841.492
Error7.98
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4355

Identifiers and class information

Inchi keyUGMWBGKFEUXCMG-UHFFFAOYNA-N
SmilesOCC1OC(OC2C(O)C(O)C(OC2OC3CCC4(C)C(CCC5(C)C4CC(O)C6C(CCC65C)C(O)(C)CCC(O)C(O)(C)C)C3(C)C)CO)C(O)C(O)C1O
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)14
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)22
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)819.038
Computed dipole moment(dipole)9.375
Total solvent accessible surface area (SASA)1065.12
Hydrophobic component of SASA (FOSA)725.34
Hydrophilic component of SASA (FISA)339.781
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2279.2
Number of hydrogen bond donors (donorHB)11
Number of hydrogen bond acceptors (accptHB)23.6
Free energy of solvation of dipole (dip^2/V)0.0385643
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0734868
Globularity descriptor (glob)0.786359
Predicted polarizability in cubic angstroms (QPpolrz)70.933
Predicted hexadecane/gas partition coefficient (QPlogPC16)23.725
Predicted octanol/gas partition coefficient (QPlogPoct)53.666
Predicted water/gas partition coefficient (QPlogPw)39.097
Predicted octanol/water partition coefficient (QPlogPo/w)0.281
Predicted aqueous solubility (QPlogS)-3.391
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.587
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.989
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)5.94
Predicted brain/blood partition coefficient (QPlogBB)-4.426
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.941
Predicted skin permeability, log Kp (QPlogKp)-5.669
PM3 calculated ionization potential (IP(ev))10.2
PM3 calculated electron affinity (EA(eV))-1.821
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-0.858
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)3.563
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)244.81
Number of nitrogen and oxygen atoms (#NandO)15
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SwissTargetPrediction and SEA
P05230FGF1Acidic fibroblast growth factorT18639SwissTargetPrediction and SEA
P09038FGF2Basic fibroblast growth factorT31621SwissTargetPrediction and SEA
Q9Y251HPSEHeparanaseT47623SwissTargetPrediction
P60568IL2Interleukin-2T61698SEA
P14679TYRTyrosinaseT97035SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T47623DI0020African trypanosomiasis[ICD-11: 1F51]Q9Y251HPSE
T47623DI0310Ocular disease[ICD-11: N.A.]Q9Y251HPSE
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025